Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

267
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
267
Allergic Reactions02:06

Allergic Reactions

26.0K
Overview
26.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Advanced healthcare materials·2026
Same author

Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria.

Journal of inflammation research·2026
Same author

Albumin-based nanocarriers: Singularities, synthesis methods, clinical relevance and targeting strategies in cancer.

Acta pharmaceutica Sinica. B·2026
Same author

Hands at risk: Decoding clinical profiles and occupational causes in chronic hand eczema.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Caution in interpreting MRGPRX2 N62S as a disease-driving variant in chronic spontaneous urticaria.

The Journal of allergy and clinical immunology·2025
Same author

Fluidity as a key determinant of stability in PEGylated lipid nanoparticles loaded with a TLR7 agonist.

International journal of pharmaceutics·2025

Related Experiment Video

Updated: Apr 22, 2026

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.8K

Nanoparticle based-immunotherapy against allergy.

Carlos Gamazo1, Gabriel Gastaminza, Marta Ferrer

  • 1University of Navarra Dept. Microbiology C/Irunlarrea, 1; 31080 - Pamplona, Spain.

Immunotherapy
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

Nanoparticles offer a novel approach to allergen-specific immunotherapy (IT), potentially improving treatment safety and speed. This method aims to reduce allergen doses and exposure, enhancing the effectiveness of allergy treatments.

Keywords:
adjuvantallergyanaphylaxisimmunotherapynanoparticle

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

12.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Related Experiment Videos

Last Updated: Apr 22, 2026

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.8K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

12.2K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Area of Science:

  • Immunology
  • Allergy Research
  • Nanomedicine

Background:

  • Allergic diseases are highly prevalent globally, affecting numerous individuals.
  • Current allergen-specific immunotherapy (IT) involves lengthy, multiple injections and carries risks.
  • There is a need for safer, faster immunotherapeutic strategies for allergies.

Purpose of the Study:

  • To review the use of nanoparticles in allergen immunotherapy.
  • To explore how nanoparticles can improve allergen delivery systems.
  • To assess the potential of nanoparticle-based IT to reduce allergen dose and exposure.

Main Methods:

  • Review of existing literature on nanoparticle-based allergen immunotherapy.
  • Analysis of nanoparticle delivery systems for allergens.
  • Discussion of mechanisms for reduced allergen exposure and improved immune response.

Main Results:

  • Nanoparticles can serve as effective allergen delivery systems.
  • This approach may allow for reduced allergen dosage and fewer administration requirements.
  • Nanoparticle formulation can potentially decrease adverse allergic reactions.

Conclusions:

  • Nanoparticle-based allergen immunotherapy presents a promising alternative to conventional methods.
  • This strategy could lead to safer, more efficient, and faster allergy treatments.
  • Further research into nanoparticle delivery systems is warranted for clinical application.